Arthur M. Cohen & Associates, LLC Sage Therapeutics, Inc. Transaction History

Arthur M. Cohen & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$54.88 - $79.29 $147,627 - $213,290	-2,690 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$58.41 - $89.06 $157,122 - $239,571	2,690 New	2,690 $233,000
Q1 2020 Apr 14, 2020	SELL	$26.15 - $77.24 $77,665 - $229,402	-2,970 Closed	0 $0
Q4 2019 Jan 10, 2020	SELL	$60.18 - $154.77 $43,690 - $112,363	-726 Reduced 19.64%	2,970 $214,000
Q2 2019 Jul 29, 2019	SELL	$157.85 - $183.09 $723,742 - $839,467	-4,585 Reduced 55.37%	3,696 $677,000
Q3 2014 Nov 08, 2017	BUY	N/A	8,281	8,281 $589,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $284M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.